Page last updated: 2024-11-04

temozolomide and Sarcoma, Synovial

temozolomide has been researched along with Sarcoma, Synovial in 2 studies

Sarcoma, Synovial: A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1363)

Research Excerpts

ExcerptRelevanceReference
"Synovial sarcoma is a soft-tissue sarcoma and a rare type of cancer."1.43Synovial sarcoma cell lines showed reduced DNA repair activity and sensitivity to a PARP inhibitor. ( Kondo, T; Miyamoto, M; Ohta, T; Watanabe, T; Yamamoto, Y; Yamasaki, H, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bazan, F1
Vollmer, I1
Gayete, A1
Yamasaki, H1
Miyamoto, M1
Yamamoto, Y1
Kondo, T1
Watanabe, T1
Ohta, T1

Other Studies

2 other studies available for temozolomide and Sarcoma, Synovial

ArticleYear
Chemotherapy-induced secondary pneumothorax.
    Archivos de bronconeumologia, 2014, Volume: 50, Issue:1

    Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizuma

2014
Synovial sarcoma cell lines showed reduced DNA repair activity and sensitivity to a PARP inhibitor.
    Genes to cells : devoted to molecular & cellular mechanisms, 2016, Volume: 21, Issue:8

    Topics: Cell Line, Tumor; Cell Proliferation; Dacarbazine; DNA Damage; DNA Repair; Etoposide; Humans; Phthal

2016